Behind the Paper
The real stories behind the latest research papers, from conception to publication, the highs and the lows
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomized clinical trial
https://www.nature.com/articles/s41416-020-01140-9